Preclinical Investigations Reveal the Broad-Spectrum Neutralizing Activity of Peptide Pep19-2.5 on Bacterial Pathogenicity Factors

Lena Heinbockel, Susana Sánchez-Gómez, Guillermo Martinez de Tejada, Sabine Dömming, Julius Brandenburg, Yani Kaconis, Mathias Hornef, Aline Dupont, Sebastian Marwitz, Torsten Goldmann, Martin Ernst, Thomas Gutsmann, Tobias Schürholz, Klaus Brandenburg
  • Antimicrobial Agents and Chemotherapy, January 2013, ASM Journals
  • DOI: 10.1128/aac.02066-12

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1128/aac.02066-12

The following have contributed to this page: Professor Torsten Goldmann